Baoling Ying

3.9k total citations
38 papers, 970 citations indexed

About

Baoling Ying is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Baoling Ying has authored 38 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 19 papers in Infectious Diseases and 15 papers in Molecular Biology. Recurrent topics in Baoling Ying's work include Virus-based gene therapy research (25 papers), Viral gastroenteritis research and epidemiology (12 papers) and CAR-T cell therapy research (12 papers). Baoling Ying is often cited by papers focused on Virus-based gene therapy research (25 papers), Viral gastroenteritis research and epidemiology (12 papers) and CAR-T cell therapy research (12 papers). Baoling Ying collaborates with scholars based in United States, United Kingdom and China. Baoling Ying's co-authors include William S.M. Wold, Ann E. Tollefson, Károly Tóth, Jacqueline F. Spencer, Michael Diamond, Konstantin Doronin, R. Mark L. Buller, John E. Sagartz, Rita E. Chen and Swathi Shrihari and has published in prestigious journals such as Nature Immunology, Cancer Research and Journal of Virology.

In The Last Decade

Baoling Ying

37 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baoling Ying United States	20	446	446	430	220	210	38	970
Marko Marttila Sweden	7	336 0.8×	506 1.1×	192 0.4×	90 0.4×	143 0.7×	8	624
Autumn Ruiz United States	13	229 0.5×	200 0.4×	259 0.6×	221 1.0×	278 1.3×	20	818
Jacqueline F. Spencer United States	20	590 1.3×	925 2.1×	330 0.8×	107 0.5×	228 1.1×	35	1.1k
Patrick Hong United States	12	303 0.7×	143 0.3×	171 0.4×	337 1.5×	247 1.2×	17	832
Qingmei Jia United States	16	241 0.5×	120 0.3×	212 0.5×	95 0.4×	410 2.0×	30	763
Peihong Dai United States	12	397 0.9×	129 0.3×	404 0.9×	802 3.6×	204 1.0×	17	1.0k
Mang Yu United States	10	433 1.0×	241 0.5×	189 0.4×	141 0.6×	298 1.4×	16	795
Hanxin Lu United States	18	352 0.8×	84 0.2×	399 0.9×	321 1.5×	589 2.8×	26	1.3k
Murty Chengalvala Canada	14	227 0.5×	292 0.7×	151 0.4×	101 0.5×	159 0.8×	26	576
Nicolin Bloch United States	11	451 1.0×	125 0.3×	336 0.8×	623 2.8×	361 1.7×	13	1.3k

Countries citing papers authored by Baoling Ying

Since Specialization

Citations

This map shows the geographic impact of Baoling Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoling Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoling Ying more than expected).

Fields of papers citing papers by Baoling Ying

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoling Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoling Ying. The network helps show where Baoling Ying may publish in the future.

Co-authorship network of co-authors of Baoling Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Baoling Ying. A scholar is included among the top collaborators of Baoling Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoling Ying. Baoling Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ying, Baoling, Chieh-Yu Liang, Pritesh Desai, et al.. (2024). Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain. Journal of Virology. 98(9). e0057424–e0057424. 3 indexed citations

Tollefson, Ann E., Baoling Ying, Jacqueline F. Spencer, et al.. (2024). Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters. Antiviral Research. 222. 105799–105799. 4 indexed citations

Ying, Baoling, Tamarand L. Darling, Pritesh Desai, et al.. (2024). Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection. Nature Immunology. 25(3). 537–551. 18 indexed citations

Ying, Baoling, Bradley Whitener, Laura A. VanBlargan, et al.. (2022). Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Science Translational Medicine. 14(630). eabm3302–eabm3302. 36 indexed citations

Darling, Tamarand L., Baoling Ying, Bradley Whitener, et al.. (2022). mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2. Med. 3(5). 309–324.e6. 6 indexed citations

Case, James Brett, Rita E. Chen, Longxing Cao, et al.. (2021). Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host & Microbe. 29(7). 1151–1161.e5. 40 indexed citations

Li, Minghua, Max Ferretti, Baoling Ying, et al.. (2021). Pharmacological activation of STING blocks SARS-CoV-2 infection. Science Immunology. 6(59). 143 indexed citations

Hassan, Ahmed O., Swathi Shrihari, Matthew J. Gorman, et al.. (2021). An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Reports. 36(4). 109452–109452. 86 indexed citations

Tóth, Károly, Jacqueline F. Spencer, Baoling Ying, et al.. (2018). USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses. Antiviral Research. 153. 1–9. 21 indexed citations

10.

Miao, Jinxin, Baoling Ying, Rong Li, et al.. (2018). Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9. Viruses. 10(5). 243–243. 21 indexed citations

11.

Tóth, Károly, Ann E. Tollefson, Jacqueline F. Spencer, Baoling Ying, & William S.M. Wold. (2017). Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds. Antiviral Research. 146. 121–129. 9 indexed citations

12.

Ying, Baoling, Jacqueline F. Spencer, Ann E. Tollefson, William S.M. Wold, & Károly Tóth. (2017). Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females. Virology. 514. 66–78. 11 indexed citations

13.

Tóth, Károly, Baoling Ying, Jacqueline F. Spencer, et al.. (2015). STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control. PLoS Pathogens. 11(8). e1005084–e1005084. 43 indexed citations

14.

Ying, Baoling, Károly Tóth, Jacqueline F. Spencer, Rajeev Aurora, & William S.M. Wold. (2015). Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters. Virology. 485. 305–312. 16 indexed citations

15.

Young, Bessie A., Jacqueline F. Spencer, Baoling Ying, et al.. (2013). The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors. Cancer Gene Therapy. 20(9). 521–530. 17 indexed citations

16.

Young, Bessie A., Jacqueline F. Spencer, Baoling Ying, Károly Tóth, & William S.M. Wold. (2013). The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model. Cancer Gene Therapy. 20(9). 531–537. 7 indexed citations

17.

Ying, Baoling, Károly Tóth, Jacqueline F. Spencer, et al.. (2009). INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Therapy. 16(8). 625–637. 47 indexed citations

18.

Ying, Baoling & William S.M. Wold. (2003). Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B. Virology. 313(1). 224–234. 24 indexed citations

19.

Ying, Baoling, Kimberley Smith, & Katherine R. Spindler. (1998). Mouse Adenovirus Type 1 Early Region 1A Is Dispensable for Growth in Cultured Fibroblasts. Journal of Virology. 72(8). 6325–6331. 11 indexed citations

20.

Smith, Kimberley, Baoling Ying, Amy Oberhauser Ball, Clayton W. Beard, & Katherine R. Spindler. (1996). Interaction of Mouse Adenovirus Type 1 Early Region 1A Protein with Cellular Proteins pRb and p107. Virology. 224(1). 184–197. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact